HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget disease by receptor activator of nuclear factor kappa B (RANK) ligand/RANK pathways.

AbstractBACKGROUND:
Extramammary Paget disease (EMPD) is a skin adenocarcinoma of apocrine gland origin, in which Paget cells express receptor activator of nuclear factor kappa B (RANK) ligand (RANKL) and matrix metalloproteinase (MMP)-7, and release soluble (s)RANKL into the tumour microenvironment. We previously reported that about 60% of the RANK+ cells among the stromal cells are M2 macrophages, but the identity of the remaining population of RANK+ cells is still unknown.
OBJECTIVES:
To investigate the unknown subpopulation of RANK-expressing cells in EMPD.
METHODS:
The main population of RANK-expressing cells in the epidermis was composed of epidermal Langerhans cells (LCs). To explore the effects of RANKL on LCs, we stimulated LCs generated from human CD34+ hematopoietic progenitor cells with graded concentrations of sRANKL. To further examine the correlation between LCs and regulatory T cells (Tregs) in EMPD, we employed immunohistochemical staining.
RESULTS:
sRANKL stimulation was shown to augment the production of C-C motif chemokine ligand 17 (CCL17) from LCs. We additionally demonstrated CCL17 expression by CD1a+ LCs in EMPD in an immunofluorescence study. Spearman's rank correlation test confirmed a correlation between the number of LCs and the number of Foxp3+ Tregs in the lesional skin of invasive EMPD. In addition, the numbers of Foxp3+ Tregs in the sentinel lymph nodes of metastatic EMPD were significantly higher than those of metastatic melanoma, which did not express RANKL.
CONCLUSIONS:
The findings suggest that the RANKL/RANK pathway in EMPD might contribute to the recruitment of Tregs and to maintenance of the tumour microenvironment.
AuthorsT Fujimura, Y Kambayashi, S Furudate, A Kakizaki, T Hidaka, S Aiba
JournalThe British journal of dermatology (Br J Dermatol) Vol. 176 Issue 2 Pg. 387-394 (Feb 2017) ISSN: 1365-2133 [Electronic] England
PMID27411503 (Publication Type: Journal Article)
Copyright© 2016 British Association of Dermatologists.
Chemical References
  • Chemokine CCL17
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • NF-kappa B
  • RANK Ligand
Topics
  • Chemokine CCL17 (metabolism)
  • Forkhead Transcription Factors (metabolism)
  • Humans
  • Langerhans Cells (physiology)
  • Lymphatic Metastasis
  • NF-kappa B (metabolism)
  • Paget Disease, Extramammary (metabolism)
  • RANK Ligand (metabolism)
  • Receptor Cross-Talk (physiology)
  • Skin Neoplasms (metabolism)
  • T-Lymphocytes, Regulatory (physiology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: